"Morris and Gordon summarize a wealth of information about the genes for hereditary breast cancer so that women with a BRCA1 or BRCA2 mutation may have a single reference to guide them when faced with difficult decisions about risk management." --Steven Narod, MD, Canada Research Chair in Breast Cancer, Women's College Hospital, Toronto
"Positive Results: Making the Best Decisions When You're at High Risk of Breast or Ovarian Cancer is a book long overdue. It demystifies the BRCA journey and provides a roadmap to guide, teach, inspire, and comfort." --Selma Schimmel, founder & CEO of Vital Options International. Host of The Group Room® cancer talk radio show and author of Cancer Talk: Voices of Hope and Endurance from The Group Room, the World's Largest Cancer Support Group.
"I learned I was positive for the BRCA2 mutation at age 34 -- 7 years younger than my mother was at her first diagnosis of breast cancer. Shortly thereafter, facing unthinkable choices and desperate for information, I had the good fortune to meet Joi and read Positive Results. This book answered every question I had, anticipated many that hadn't yet occurred to me, and continues to serve as an invaluable resource as I weigh my risk management options. Positive Results has helped me to take an informed, proactive approach to my genetic status, and I would recommend it to anyone at high risk for breast and ovarian cancer, at every step of his or her journey." --Suzanne Ennis, BRCA2+, Manhattan Beach, CA
"Positive Results is a superbly written guidebook for men and women whose families are afflicted with breast or ovarian cancer....Everybody needs to read this book!!" ----Howard C. Mandel M.D., former Chief of Gynecology of Century City Hospital and Chief of Gynecology and Chief of Surgery of Century City Doctors' Hospital
About the Author
Ora Karp Gordon, MD, MS (Tarzana, CA) is director of the GenRISK Adult Genetics Program at Cedars-Sinai Medical Center in Los Angeles, the largest clinical adult genetics program on the West Coast. She is also codirector of the Cedars-Sinai Gilda Radner Ovarian and Breast Cancer Screening Program for high-risk women and associate professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles.